GHK‑Cu (Copper Peptide) – Manual & Dosage Protocol Guide
What Is GHK‑Cu?
GHK‑Cu (Copper Tripeptide‑1) is a naturally occurring peptide complex found in human plasma that plays a role in tissue repair, collagen synthesis, antioxidation, and cellular signaling. It declines with age and has been extensively studied in regenerative biology, dermatological research, and wound‑healing models. (Peptide Initiative)
Key Mechanisms (Research):• Stimulates collagen and elastin production• Enhances angiogenesis and fibroblast activity• Modulates antioxidant enzymes and oxidative stress• Supports wound healing and tissue regeneration (Peptide Initiative)
Forms Available (Research Only)
Lyophilized Powder – Freeze‑dried GHK‑Cu for reconstitution
Injectable Solution (SC or IM) – Subcutaneous or intramuscular injection after reconstitution
Topical Formulation – Creams, serums, or gels with GHK‑Cu for skin models
Experimental Dosage Protocols
Note: Reported doses vary across laboratories and models. Below are common research dosing patterns, not clinical prescriptions. (The Peptide Stack)
Subcutaneous (SC) / Injectable Use
Anti‑aging / Skin Health – Typical Dose: 1–2 mg/day | Frequency: Daily | Duration: 8–16 weeks
Tissue Repair / Wound Healing – Typical Dose: 2–3 mg/day | Frequency: Daily | Duration: 4–8 weeks
General Recovery – Typical Dose: 1–3 mg/day | Frequency: Daily | Duration: Study dependent
*Some protocols begin at 1 mg/day to assess tolerance and may progress up to 2–3 mg/day. (seekpeptides.com)
Typical injection is subcutaneous, often in the abdominal area, thigh, or upper arm. (seekpeptides.com)
Reconstitution Instructions (Lyophilized Powder)
Supplies:
- Sterile bacteriostatic water
- Sterile syringes & alcohol swabs
Protocol:
- Disinfect vial rubber stopper with alcohol.
- Add bacteriostatic water appropriately. For example:
- If 50 mg vial + 2 mL water → 25 mg/mL concentration.
- Swirl gently to dissolve (do not shake).
- Refrigerate after reconstitution (2–8 °C), and use within ~2–4 weeks. (Peptide Initiative)
Administration Guidelines
Subcutaneous Injection (SC)
- Clean the injection site with an alcohol swab.
- Pinch the skin and inject at a 45° angle.
- Inject slowly, then apply gentle pressure.
- Rotate sites to reduce local irritation. (seekpeptides.com)
Topical Application (Skin Models)
- Apply to clean, dry skin once or twice daily at a chosen concentration (e.g., as part of experimental cosmetic models). (Peptide Database)
Topical Application (Skin Models)
Apply to clean, dry skin once or twice daily at a chosen concentration (e.g., as part of experimental cosmetic models). (Peptide Database)
Storage Guidelines
Storage Information
Lyophilized Powder – Store frozen or refrigerated (recommended −20 °C / 2–8 °C)
Reconstituted Solution – Refrigerate 2–8 °C, protect from light
Topical Formulation – Follow manufacturer formulation instructions
Protect from light and repeated freeze–thaw cycles to maintain peptide integrity. (Peptide Hackers)
Observed Research Effects
Research systems have reported:
- Collagen and elastin upregulation in skin models
- Accelerated wound closure and dermal repair
- Antioxidant gene activation and reduced oxidative markers
- Hair follicle stimulation in preclinical settings (Peptide Initiative)
Safety & Precautions (Research Use Only)
- Use in controlled research environments only (cell culture, animal models, ex vivo tissues).
- Not approved for human or clinical therapeutic use.
- Possible injection discomfort due to copper ion (some lab reports of local irritation).
Avoid contamination and adhere to sterile technique. (seekpeptides.com)
Cycle & Duration (Experimental)
Cycle Pattern
Daily Protocol – 4–12 weeks continuous administration
On/Off Cycles – Some experimental designs use 6–8 weeks on, then rest intervals
Maintenance – Low‑dose or intermittent protocols vary by model
Cycling in research is determined by study design and endpoint measures (not standardized). (seekpeptides.com)
Quick Reference (Experimental)
Peptide: GHK‑Cu (Copper Tripeptide‑1)
Typical BV: ~1–3 mg/day SC in research models
Duration: 4–16 weeks (study‑dependent)
Administration: Subcutaneous injection or topical formulation
Storage: Refrigerate reconstituted solutions (2–8 °C)
Safety: Research only, not for human therapeutic use